X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
partial-onset seizures (871) 871
humans (659) 659
clinical neurology (610) 610
epilepsy (607) 607
anticonvulsants - therapeutic use (464) 464
antiepileptic drugs (387) 387
male (356) 356
double-blind (340) 340
female (340) 340
adult (319) 319
seizures (315) 315
efficacy (312) 312
anticonvulsants - adverse effects (274) 274
epilepsy - drug therapy (269) 269
treatment outcome (263) 263
middle aged (245) 245
safety (242) 242
neurology (232) 232
adolescent (219) 219
pharmacology & pharmacy (215) 215
epilepsies, partial - drug therapy (202) 202
young adult (180) 180
lacosamide (177) 177
neurosciences (177) 177
anticonvulsants (166) 166
aged (165) 165
anticonvulsants - administration & dosage (164) 164
psychiatry (160) 160
adjunctive therapy (159) 159
adults (147) 147
analysis (142) 142
drug therapy (141) 141
child (135) 135
dose-response relationship, drug (132) 132
drug therapy, combination (124) 124
levetiracetam (122) 122
placebo-controlled trial (122) 122
refractory epilepsy (119) 119
seizures - drug therapy (118) 118
clinical trials (116) 116
tolerability (113) 113
randomized phase-iii (110) 110
animals (109) 109
pharmacokinetics (107) 107
add-on therapy (106) 106
eslicarbazepine acetate (106) 106
randomized controlled-trial (106) 106
perampanel (103) 103
antiepileptic drug (102) 102
double-blind method (102) 102
acetamides - therapeutic use (101) 101
children (98) 98
anticonvulsants - pharmacology (97) 97
behavioral sciences (97) 97
carbamazepine (97) 97
adjunctive perampanel (96) 96
therapy (94) 94
monotherapy (92) 92
anticonvulsants - pharmacokinetics (91) 91
drugs (89) 89
phase-iii (89) 89
retrospective studies (88) 88
care and treatment (81) 81
convulsions & seizures (71) 71
oral lacosamide (71) 71
drug resistance (68) 68
medical research (68) 68
piracetam - analogs & derivatives (67) 67
topiramate (67) 67
adjunctive treatment (65) 65
status epilepticus (65) 65
medicine & public health (64) 64
pyridones - therapeutic use (64) 64
antiepileptic agents (62) 62
pediatrics (62) 62
acetamides - adverse effects (61) 61
brivaracetam (61) 61
focal epilepsy (61) 61
oxcarbazepine (61) 61
child, preschool (60) 60
randomized controlled trials as topic (58) 58
adjunctive brivaracetam (57) 57
follow-up studies (57) 57
fructose - analogs & derivatives (57) 57
drug administration schedule (56) 56
multicenter (55) 55
lamotrigine (53) 53
medicine, experimental (53) 53
trial (53) 53
acetamides - administration & dosage (51) 51
drug dosages (51) 51
drug interactions (51) 51
patients (51) 51
refractory partial seizures (49) 49
dosage and administration (48) 48
fructose - therapeutic use (48) 48
pharmacotherapy (48) 48
quality of life (47) 47
clinical trials as topic (46) 46
quality-of-life (46) 46
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (887) 887
German (16) 16
Spanish (16) 16
Russian (7) 7
French (3) 3
Hungarian (3) 3
Japanese (2) 2
Czech (1) 1
Korean (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Epilepsia, ISSN 0013-9580, 07/2007, Volume 48, Issue 7, pp. 1308 - 1317
Journal Article
Journal Article
Seminars in Fetal and Neonatal Medicine, ISSN 1744-165X, 2013, Volume 18, Issue 4, pp. 216 - 223
Summary The treatment of neonatal seizures has not changed significantly over the last 50 years despite advances in antiepileptic drug (AED... 
Neonatal and Perinatal Medicine | Topiramate | Newborn | Seizures neonatal | Drug trials | Bumetanide | Antiepileptic drug treatment | Levetiracetam | REFRACTORY STATUS EPILEPTICUS | ADJUNCTIVE TOPIRAMATE | PARTIAL-ONSET SEIZURES | INTRAVENOUS LEVETIRACETAM | IN-VITRO | NEUROLOGICAL-DISORDERS | IDIOPATHIC GENERALIZED EPILEPSY | CRITICALLY ILL INFANTS | HYPOXIC-ISCHEMIC ENCEPHALOPATHY | PEDIATRICS | ANTIEPILEPTIC DRUGS | Neuroprotective Agents - therapeutic use | Neurons - pathology | Sodium Potassium Chloride Symporter Inhibitors - therapeutic use | Humans | Piracetam - adverse effects | Seizures - drug therapy | Sodium Potassium Chloride Symporter Inhibitors - adverse effects | Bumetanide - therapeutic use | Anticonvulsants - adverse effects | Seizures - pathology | Piracetam - therapeutic use | Child Development - drug effects | Neurogenesis - drug effects | Neuroprotective Agents - adverse effects | Neurons - drug effects | Infant, Newborn | Bumetanide - adverse effects | Fructose - adverse effects | Anticonvulsants - therapeutic use | Fructose - therapeutic use | Brain - drug effects | Fructose - analogs & derivatives | Animals | Piracetam - analogs & derivatives | Brain - pathology | Epilepsy - drug therapy | Epilepsy - pathology | Infants (Newborn) | Care and treatment | Anticonvulsants | Child development | Diuretics | Seizures (Medicine) | Target marketing
Journal Article
Expert Review of Neurotherapeutics, ISSN 1473-7175, 01/2009, Volume 9, Issue 1, pp. 33 - 42
Journal Article
Epilepsia, ISSN 0013-9580, 01/2013, Volume 54, Issue 1, pp. 98 - 107
Journal Article
Journal Article